Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial

Radiotherapy and Oncology

Volumn 90, Issue 3, 2009, Pages 400-407

  Capp, Anne ^a   Inostroza Ponta, Mario ^b   Bill, Dana ^l   Moscato, Pablo ^b   Lai, Chi ^l   Christie, David ^c   Lamb, David ^d   Turner, Sandra ^e   Joseph, David ^f   Matthews, John ^g   Atkinson, Chris ^h   North, John ⁱ   Poulsen, Michael ^j   Spry, Nigel A ^f   Tai, Keen Hun ^k   Wynne, Chris ⁱ   Duchesne, Gillian ^k   Steigler, Allison ^l   Denham, James W ^l  

^a CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Premion   (Australia)

^d WELLINGTON HOSPITAL   (New Zealand)

^e WESTMEAD HOSPITAL   (Australia)

^f SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h CHRISTCHURCH HOSPITAL   (New Zealand)

ⁱ DUNEDIN HOSPITAL   (New Zealand)

^j Southern Zone Radiation Oncology   (Australia)

^k PETER MACCALLUM CANCER CENTRE   (Australia)

^l UNIVERSITY OF NEWCASTLE   (Australia)

more..

Author keywords

CTC scale; Proctitis; Radiation rectal toxicity

Indexed keywords

FLUTAMIDE; GOSERELIN;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; QUESTIONNAIRE; RECTUM DISEASE; SELF EVALUATION;

ANDROGEN ANTAGONISTS; HUMANS; MALE; NEOADJUVANT THERAPY; PROCTITIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY; SYNDROME;

EID: 61349141208     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.09.019     Document Type: Article

References (21)

1. Christie D.R.H., Denham J.W., Steigler A., Lamb D.S., Turner S., Mameghan H., et al. Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation. Radiother Oncol 77 (2005) 117-125
2. Public Health Service, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Effects v3.0 (CTCAE); 2006.
3. Denham J.W., O'Brien P.C., Dunstan R.H., Johansen J., See A., Hamilton C.S., et al. Is there more than one late radiation proctitis syndrome?. Radiother Oncol 51 (1999) 43-53
4. LENT SOMA Tables. Radiother Oncol 1995;35:17-60.
5. Dearnaley D.P., Hall E., Lawrence D., Huddart R.A., Eeles R., Nutting C.M., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 92 (2005) 488-498
6. Hofer M., Pospisil M., Tkadlecek L., Viklická S., Pipalová I., and Holá J. Low survival of mice following lethal gamma-irradiation after administration of inhibitors of prostaglandin synthesis. Physiol Res 41 (1992) 157-161
7. Litwin M.S., Hays R.D., Fink A., Ganz P.A., Leake B., Leach G.E., et al. Quality-of-life outcomes in men treated for localized prostate cancer. J Am Med Assoc 273 (1995) 129-135
8. Inostroza-Ponta M, Berretta R, Mendes A, Moscato P. An automatic graph layout procedure to visualize correlated data. In: Bramer M, editors. Artificial intelligence in theory and practice: IFIP 19th world computer congress, vol. 217 of IFIP international federation for information processing ed.; 2006. p. 179-88.
9. Inostroza-Ponta M, Mendes A, Berretta R, Moscato P. An integrated QAP-based approach to visualize patterns of gene expression similarity. In: Randall M, Abbass H, Wiles J, editors. Lecture notes in artificial intelligence - Australian conference on artificial life 2007, vol. 4828 ed.; 2007. p. 156-67.
10. Henderson A., Andreyev H.J., Stephens R., and Dearnaley D. Patient and physician reporting of symptoms and health-related quality of life in trials of treatment for early prostate cancer: considerations for future studies. Clin Oncol 18 (2006) 735-743
11. O'Brien P.C., Hamilton C.S., Denham J.W., Gourlay R., and Franklin C.I.V. Spontaneous improvement in late rectal mucosal changes following radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 75-80
12. Hovdenak N., Fajardo L.F., and Hauer-Jensen M. Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys 48 (2000) 1111-1117
13. Karlsdottir A., Muren L.P., Wentzel-Larsen T., and Dahl O. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. Int J Radiat Oncol Biol Phys 70 (2008) 1478-1486
14. Heemsbergen W.D., Peeters S.T., Koper P.C.M., Hoogeman M.S., and Lebesque J.V. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. Int J Radiat Oncol Biol Phys 66 (2006) 3-10
15. Andreyev J. Gastrointestinal complications of pelvic radiotherapy: are they of any importance?. Gut 54 (2005) 1051-1054
16. Yeoh E.E.K., Holloway R.H., Fraser R.J., Botten R.J., Di Matteo A.C., Moore J.W.E., et al. Anorectal dysfunction increases with time following radiation therapy for carcinoma of the prostate. Am J Gastroenterol 99 (2004) 362-369
17. Andreyev H.J., Vlavianos P., Blake P., and Dearnaley D. Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?. Int J Radiat Oncol Biol Phys 62 (2005) 1464-1471
18. Fenwick J.D., Khoo V.S., Nahum A.E., Sanchez-Nieto B., and Dearnaley D.P. Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys 49 (2001) 473-480
19. Fiorino C., Fellin G., Rancati T., Vavassori V., Bianchi C., Borca V.C., et al. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys 70 (2008) 1130-1137
20. Van der Laan H.P., Van den Bergh A., Schilstra C., Vlasman R., Meertens H., and Langendijk J.A. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 1138-1145
21. RADAR Trial - Randomised Androgen Deprivation and Radiotherapy; 2005.